September 04, 2020
xecutives at Moderna are selling off their stock to the tune of tens of millions of dollars, leaving those watching the company’s COVID-19 vaccine wondering what’s up.
Plus, an investigation by NPR revealed even more “irregularities and potential warning signs,” leading Daniel Taylor, an associate professor of accounting at the Wharton School, to tell NPR that, “On a scale of one to 10, one being less concerned and 10 being the most concerned, this is an 11.”
“Advocates have questioned whether it’s appropriate for executives to privately profit before bringing the vaccine to market, especially when American taxpayers have committed roughly $2.5 billion to the company’s vaccine development and manufacture,” NPR said. (Click to Source)
SOURCE: NPR September 4, 2020